Fig. 5.

First‐line and second‐line treatments for active moderate‐to‐severe Graves’ orbitopathy, according to the European Group on Graves’ Orbitopathy clinical practice guidelines [80]. GCs, glucocorticoids; ivGCs, intravenous glucocorticoids.